| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of LEPR mRNA" | 26377693 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of LEPR mRNA" | 22698814 |
| C532162 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | "LEPR affects the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased phosphorylation of AKT1 protein]" | 22949526 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 25510870 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of LEPR mRNA" | 29112739 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "ESR1 gene mutant form inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of LEPR mRNA]" | 29112739 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LEPR mRNA" | 19114083 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA" | 19167446 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of LEPR mRNA" | 24978599 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of LEPR mRNA" | 24978599 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of LEPR mRNA" | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LEPR gene mutant form results in decreased expression of SOD2 protein] | 23159718 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LEPR gene mutant form results in increased phosphorylation of AKT1 protein] | 23159718 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LEPR gene mutant form results in increased phosphorylation of FOXO3 protein] | 23159718 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 25510870 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of LEPR mRNA" | 21346803 |
| C008039 | 2-hydroxyisobutyric acid | LEPR affects the abundance of 2-hydroxyisobutyric acid | 20567778 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane affects the expression of LEPR mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LEPR mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [LEPR gene mutant form results in decreased expression of SOD2 protein]" | 23159718 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [LEPR gene mutant form results in increased phosphorylation of AKT1 protein]" | 23159718 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [LEPR gene mutant form results in increased phosphorylation of FOXO3 protein]" | 23159718 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid affects the reaction [LEPR gene mutant form affects the splicing of XBP1 mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of GPD2 mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of MAFA mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of NKX6-1 mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PCX mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PDX1 mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of EDEM1 mRNA] | 23274897 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of FKBP11 mRNA] | 23274897 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LEPR mRNA" | 27188386 |
| C077646 | 7,12-benz(a)anthraquinone | "7,12-benz(a)anthraquinone results in increased expression of LEPR mRNA" | 26141390 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of LEPR mRNA | 25064622 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [LEPR gene mutant form results in increased abundance of Superoxides] | 19478208 |
| D000109 | Acetylcholine | acetovanillone inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| D000109 | Acetylcholine | LEPR gene mutant form results in decreased susceptibility to Acetylcholine | 19478208 |
| D000109 | Acetylcholine | resveratrol inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| D000109 | Acetylcholine | tempol inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| D000109 | Acetylcholine | TNF gene mutant form affects the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| C014949 | acetylhydrazine | acetylhydrazine results in decreased expression of LEPR mRNA | 15282401 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of LEPR mRNA | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of LEPR mRNA | 23630614 |
| D000481 | Allantoin | LEPR affects the abundance of Allantoin | 20567778 |
| D000493 | Allopurinol | Allopurinol inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] | 22426011 |
| C019419 | alpha-hydroxyisocaproic acid | LEPR affects the abundance of alpha-hydroxyisocaproic acid | 20567778 |
| C001918 | alpha-ketoadipic acid | LEPR affects the abundance of alpha-ketoadipic acid | 20567778 |
| C016211 | alpha-keto-beta-methylvaleric acid | LEPR affects the abundance of alpha-keto-beta-methylvaleric acid | 20567778 |
| C029743 | alpha-ketoglutaric acid | LEPR affects the abundance of alpha-ketoglutaric acid | 20567778 |
| C001505 | alpha-ketoisovalerate | LEPR affects the abundance of alpha-ketoisovalerate | 20567778 |
| D000638 | Amiodarone | Amiodarone affects the expression of LEPR mRNA | 25064622 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of LEPR mRNA | 16483693 |
| D001125 | Argininosuccinic Acid | LEPR affects the abundance of Argininosuccinic Acid | 20567778 |
| D001151 | Arsenic | Arsenic affects the methylation of LEPR gene | 25304211 |
| D001151 | Arsenic | Arsenic results in decreased expression of LEPR mRNA | 19654921 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of AIFM1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of APP mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of CAT mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of CNTD1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX15 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX5A mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX5B mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX6B1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of COX6C mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of FOXO3 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of GNA13 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of GPX3 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of GRN mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of HMGB1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of HOXA9 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of IDH1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of ND6 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFA1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFA5 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFC2 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NDUFV2 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of NME2 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of PPP1CB mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of PRDX1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of RPS2 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of SOD1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of SPP1 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of TGM2 mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of TKT mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UBB mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UQCRB mRNA] | 16964424 |
| C005948 | astaxanthine | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of UQCRC2 mRNA] | 16964424 |
| C030935 | benz(a)anthracene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA | 27858113 |
| C006703 | benzo(b)fluoranthene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA | 27858113 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of LEPR mRNA | 18164116 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of LEPR mRNA | 22316170 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA | 27858113 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of LEPR mRNA | 19770486 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of LEPR mRNA | 21839799 |
| D004958 | Estradiol | Estradiol results in decreased expression of LEPR mRNA | 19167446 |
| D004958 | Estradiol | Estradiol results in decreased expression of LEPR mRNA | 14664709 |
| D004958 | Estradiol | [bisphenol A co-treated with Estradiol] results in decreased expression of LEPR mRNA | 26496021 |
| D004958 | Estradiol | LEPR protein affects the abundance of Estradiol | 15093691 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LEPR mRNA | 22343039 |
| C006780 | bisphenol A | bisphenol A results in increased expression of LEPR protein | 22343039 |
| C006780 | bisphenol A | [bisphenol A co-treated with Estradiol] results in decreased expression of LEPR mRNA | 26496021 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of LEPR mRNA | 25181051 |
| D001786 | Blood Glucose | LEPR gene mutant form inhibits the reaction [sodium arsenite results in increased abundance of Blood Glucose] | 25367288 |
| D001786 | Blood Glucose | LEPR gene mutant form results in increased abundance of Blood Glucose | 25367288 |
| D001786 | Blood Glucose | sodium arsenite inhibits the reaction [LEPR gene mutant form results in increased abundance of Blood Glucose] | 25367288 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]] | 19849856 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]] | 19849856 |
| C025191 | bromodichloromethane | LEPR protein affects the reaction [[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein] | 23438451 |
| C025191 | bromodichloromethane | LEPR protein results in decreased susceptibility to [Dietary Fats co-treated with bromodichloromethane] | 23438451 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of LEPR mRNA | 26079696 |
| D020148 | Butyric Acid | LEPR affects the abundance of Butyric Acid | 20567778 |
| D002110 | Caffeine | Caffeine results in decreased expression of LEPR mRNA | 26367767 |
| D002110 | Caffeine | Caffeine results in increased expression of LEPR mRNA | 22583948 |
| D002118 | Calcium | Calcium affects the expression of LEPR mRNA | 15913539 |
| D002251 | Carbon Tetrachloride | "Drugs, Chinese Herbal inhibits the reaction [[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LEPR protein]" | 18227024 |
| D002331 | Carnitine | LEPR affects the abundance of Carnitine | 20567778 |
| D002746 | Chlorpromazine | Chlorpromazine affects the expression of LEPR mRNA | 25064622 |
| D008076 | Cholesterol, HDL | "LEPR polymorphism affects the abundance of Cholesterol, HDL" | 14625131 |
| D008078 | Cholesterol, LDL | "LEPR polymorphism affects the abundance of Cholesterol, LDL" | 14625131 |
| D002794 | Choline | LEPR affects the abundance of Choline | 20567778 |
| D002794 | Choline | LEPR gene mutant form affects the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased activity of GPT protein] | 24384915 |
| D002794 | Choline | LEPR gene mutant form affects the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCB1A mRNA] | 24384915 |
| D002794 | Choline | LEPR gene mutant form affects the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCC4 mRNA] | 24384915 |
| D002794 | Choline | [LEPR gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCB1A protein | 24384915 |
| D002794 | Choline | [LEPR gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCC3 mRNA | 24384915 |
| D002794 | Choline | [LEPR gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCC3 protein | 24384915 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LEPR mRNA | 20938992 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of BTC mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of DDHD1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of PCK1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of TTPA mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of UCP1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ASPH mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of CASQ1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of EDNRB mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ENO3 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of GPI1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of NRAP mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of RALGAPA1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of SRL mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TLN1 mRNA] | 16940432 |
| D002857 | Chromium | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TPM1 mRNA] | 16940432 |
| C031180 | chrysene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of LEPR mRNA | 27858113 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of LEPR mRNA | 18353800 |
| D019343 | Citric Acid | LEPR affects the abundance of Citric Acid | 20567778 |
| D002994 | Clofibrate | Clofibrate results in increased expression of LEPR mRNA | 22008536 |
| D002995 | Clofibric Acid | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LEPR mRNA | 17602206 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA" | 19167446 |
| D003375 | Coumestrol | Coumestrol results in decreased expression of LEPR mRNA | 19167446 |
| C513821 | CPU0213 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEPR mRNA] | 20307649 |
| C513821 | CPU0213 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEPR protein] | 20307649 |
| D003404 | Creatinine | LEPR affects the abundance of Creatinine | 20567778 |
| D016572 | Cyclosporine | Cyclosporine affects the expression of LEPR mRNA | 25064622 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of LEPR mRNA | 27989131 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of LEPR mRNA | 21198554 |
| C531198 | dactolisib | LEPR affects the reaction [dactolisib results in decreased phosphorylation of AKT1 protein] | 22949526 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased expression of LEPR mRNA | 23640034 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of LEPR mRNA | 23640034|2391405 |
| C014347 | decitabine | decitabine results in decreased expression of LEPR | 22560341 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of LEPR mRNA | 21266533 |
| D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of LEPR mRNA | 28962523 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of LEPR mRNA | 27392435 |
| D004008 | Diclofenac | Diclofenac affects the expression of LEPR mRNA | 26934552 |
| D004008 | Diclofenac | Diclofenac results in increased expression of LEPR protein | 26934552 |
| C000944 | dicrotophos | dicrotophos results in increased expression of LEPR mRNA | 28302478 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of LEPR mRNA | 25016146 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of LEPR mRNA | 22276206 |
| D004041 | Dietary Fats | LEPR protein affects the reaction [[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein] | 23438451 |
| D004041 | Dietary Fats | LEPR protein promotes the reaction [Dietary Fats results in increased expression of SOCS3 mRNA] | 22276206 |
| D004041 | Dietary Fats | LEPR protein results in decreased susceptibility to [Dietary Fats co-treated with bromodichloromethane] | 23438451 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of LEPR mRNA | 18721800|2271538 |
| D004041 | Dietary Fats | [LEPR gene mutant form co-treated with Dietary Fats] results in decreased expression of SLCO1A1 mRNA | 24384915 |
| D004041 | Dietary Fats | [LEPR gene mutant form co-treated with Dietary Fats] results in increased activity of GPT protein | 24384915 |
| C014476 | diethyl maleate | diethyl maleate results in decreased expression of LEPR mRNA | 21161181 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of LEPR mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of LEPR mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of LEPR mRNA | 18164116 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LEPR mRNA | 17602206 |
| D004280 | Dobutamine | LEPR protein affects the susceptibility to Dobutamine | 20175764 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal inhibits the reaction [[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LEPR protein]" | 18227024 |
| D004970 | Estrone | Estrone inhibits the reaction [LEPR gene mutant form inhibits the reaction [EGFR protein results in increased phosphorylation of EGFR protein]] | 1753381 |
| D004970 | Estrone | Estrone inhibits the reaction [LEPR gene mutant form results in decreased expression of EGFR mRNA] | 1753381 |
| D000431 | Ethanol | [Zinc deficiency co-treated with Ethanol] results in increased expression of LEPR mRNA | 24155903 |
| D000431 | Ethanol | "Drugs, Chinese Herbal inhibits the reaction [[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LEPR protein]" | 18227024 |
| D000431 | Ethanol | Ethanol results in decreased expression of LEPR mRNA | 16098508 |
| D000431 | Ethanol | LEPR gene mutant form inhibits the reaction [Ethanol results in increased expression of MT1A mRNA] | 15475485 |
| D000431 | Ethanol | LEPR gene mutant form inhibits the reaction [Ethanol results in increased expression of MT1A protein] | 15475485 |
| D000431 | Ethanol | LEPR gene mutant form inhibits the reaction [Ethanol results in increased expression of MT2A mRNA] | 15475485 |
| D000431 | Ethanol | LEPR gene mutant form promotes the reaction [Ethanol results in increased expression of TNF mRNA] | 15475485 |
| D000431 | Ethanol | LEPR gene mutant form results in increased susceptibility to Ethanol | 15475485 |
| D000431 | Ethanol | [LEPR gene mutant form results in increased susceptibility to Ethanol] which results in decreased abundance of Zinc | 15475485 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of LEPR mRNA | 25064622 |
| D004997 | Ethinyl Estradiol | ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of LEPR mRNA] | 29112739 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of LEPR mRNA | 17942748|2911273 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LEPR mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of LEPR mRNA | 26865667 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of LEPR mRNA | 17351261 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased mutagenesis of LEPR gene | 16724327 |
| C074031 | exenatide | exenatide inhibits the reaction [LEPR gene mutant form results in decreased expression of SLC30A8 mRNA] | 21461562 |
| C074031 | exenatide | exenatide inhibits the reaction [LEPR gene mutant form results in decreased expression of SLC30A8 protein] | 21461562 |
| D005411 | Flame Retardants | ESR1 gene mutant form inhibits the reaction [Flame Retardants results in increased expression of LEPR mRNA] | 29112739 |
| D005411 | Flame Retardants | Flame Retardants results in increased expression of LEPR mRNA | 29112739 |
| D005485 | Flutamide | Flutamide results in decreased expression of LEPR mRNA | 24136188 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LEPR mRNA | 20938992 |
| C030544 | formic acid | LEPR affects the abundance of formic acid | 20567778 |
| D005632 | Fructose | Allopurinol inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] | 22426011 |
| D005632 | Fructose | Fructose results in increased expression of and results in increased phosphorylation of LEPR protein | 22426011 |
| D005632 | Fructose | Quercetin inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] | 22426011 |
| D005632 | Fructose | Rutin inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] | 22426011 |
| C032005 | fumaric acid | LEPR affects the abundance of fumaric acid | 20567778 |
| C039281 | furan | furan results in increased methylation of LEPR gene | 22079235 |
| C000090 | galactaric acid | LEPR affects the abundance of galactaric acid | 20567778 |
| D005688 | Galactosamine | Galactosamine promotes the reaction [LEPR gene mutant form results in increased expression of SPP1 mRNA] | 19913045 |
| D005688 | Galactosamine | Galactosamine promotes the reaction [LEPR gene mutant form results in increased expression of SPP1 protein] | 19913045 |
| D005688 | Galactosamine | LEPR gene mutant form results in increased susceptibility to Galactosamine | 19913045 |
| D005688 | Galactosamine | [LEPR gene mutant form results in increased susceptibility to Galactosamine] which results in increased expression of IL12B mRNA | 19913045 |
| D005688 | Galactosamine | [LEPR gene mutant form results in increased susceptibility to Galactosamine] which results in increased expression of IL18 | 19913045 |
| D005688 | Galactosamine | [LEPR gene mutant form results in increased susceptibility to Galactosamine] which results in increased expression of IL18 mRNA | 19913045 |
| D005688 | Galactosamine | [LEPR gene mutant form results in increased susceptibility to Galactosamine] which results in increased expression of IL18 protein | 19913045 |
| D005688 | Galactosamine | [LEPR gene mutant form results in increased susceptibility to Galactosamine] which results in increased expression of SPP1 protein | 19913045 |
| D005688 | Galactosamine | SPP1 promotes the reaction [LEPR gene mutant form results in increased susceptibility to Galactosamine] | 19913045 |
| C419708 | gefitinib | gefitinib results in decreased expression of LEPR mRNA | 16685379 |
| D019833 | Genistein | Genistein results in decreased expression of LEPR mRNA | 26865667 |
| D005947 | Glucose | Hesperidin affects the reaction [LEPR protein affects the abundance of Glucose] | 16427799 |
| D005947 | Glucose | LEPR affects the abundance of Glucose | 20567778 |
| D005947 | Glucose | LEPR protein affects the abundance of Glucose | 16427799 |
| D005947 | Glucose | LEPR results in decreased susceptibility to Glucose | 20567778 |
| D005947 | Glucose | naringin affects the reaction [LEPR protein affects the abundance of Glucose] | 16427799 |
| D005947 | Glucose | Glucose results in increased expression of LEPR protein | 24399619 |
| D005947 | Glucose | naringin inhibits the reaction [Glucose results in increased expression of LEPR protein] | 24399619 |
| C035736 | glutaric acid | LEPR affects the abundance of glutaric acid | 20567778 |
| C004312 | glycidol | glycidol results in decreased expression of LEPR mRNA | 24915197 |
| D006247 | Harmine | Harmine affects the reaction [LEPR protein affects the susceptibility to INS1 protein] | 27805061 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the abundance of Glucose] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the activity of FASN protein] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the activity of G6PD protein] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the activity of HMGCR protein] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the expression of GCK mRNA] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the expression of SLC2A2 protein] | 16427799 |
| D006569 | Hesperidin | Hesperidin affects the reaction [LEPR protein affects the expression of SLC2A4 protein] | 16427799 |
| C037652 | hexanoic acid | LEPR affects the abundance of hexanoic acid | 20567778 |
| C000625835 | HFPO2 compound | HFPO2 compound results in increased expression of LEPR mRNA | 27553808 |
| C000625836 | HFPO4 compound | HFPO4 compound results in increased expression of LEPR mRNA | 27553808 |
| C029424 | hydrazine | hydrazine results in increased expression of LEPR mRNA | 15370871 |
| D006852 | Hydrochlorothiazide | LEPR mutant form results in increased susceptibility to Hydrochlorothiazide | 22949526 |
| D006861 | Hydrogen Peroxide | LEPR mutant form results in increased susceptibility to Hydrogen Peroxide | 27151219 |
| D007200 | Indican | LEPR affects the abundance of Indican | 20567778 |
| C541917 | INT 131 | INT 131 inhibits the reaction [LEPR protein affects the expression of INS1 protein] | 19452630 |
| C020380 | isobutyric acid | LEPR affects the abundance of isobutyric acid | 20567778 |
| C034527 | isocaproic acid | LEPR affects the abundance of isocaproic acid | 20567778 |
| D007545 | Isoproterenol | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEPR mRNA] | 20307649 |
| D007545 | Isoproterenol | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of LEPR protein] | 20307649 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of LEPR mRNA | 20307649 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of LEPR protein | 20307649 |
| C008216 | isovaleric acid | LEPR affects the abundance of isovaleric acid | 20567778 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of LEPR mRNA | 27392435 |
| D007657 | Ketone Bodies | Ketone Bodies results in decreased expression of LEPR mRNA | 16807920 |
| D019344 | Lactic Acid | LEPR affects the abundance of Lactic Acid | 20567778 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [Thioacetamide results in decreased expression of LEPR mRNA] | 17621560 |
| C030290 | malonic acid | LEPR affects the abundance of malonic acid | 20567778 |
| D008383 | Margarine | Margarine results in increased expression of LEPR mRNA | 23038630 |
| D008628 | Mercury | Mercury results in decreased expression of LEPR mRNA | 16823088 |
| D008715 | Methionine | LEPR affects the abundance of Methionine | 20567778 |
| D008715 | Methionine | LEPR gene mutant form affects the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased activity of GPT protein] | 24384915 |
| D008715 | Methionine | LEPR gene mutant form affects the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCB1A mRNA] | 24384915 |
| D008715 | Methionine | LEPR gene mutant form affects the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCC4 mRNA] | 24384915 |
| D008715 | Methionine | [LEPR gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCB1A protein | 24384915 |
| D008715 | Methionine | [LEPR gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCC3 mRNA | 24384915 |
| D008715 | Methionine | [LEPR gene mutant form co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of ABCC3 protein | 24384915 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LEPR mRNA | 20938992 |
| D008764 | Methylmalonic Acid | LEPR affects the abundance of Methylmalonic Acid | 20567778 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of LEPR mRNA | 23179753 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of LEPR mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of LEPR mRNA | 26011545 |
| D015735 | Mifepristone | Mifepristone results in increased expression of LEPR mRNA | 19439560 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of LEPR mRNA | 25972201 |
| C548887 | MK 2206 | LEPR affects the reaction [MK 2206 results in decreased phosphorylation of AKT1 protein] | 22949526 |
| D009020 | Morphine | Morphine results in increased expression of LEPR mRNA | 20144693 |
| C016590 | N(1)-methyl-4-pyridone-5-carboxamide | LEPR affects the abundance of N(1)-methyl-4-pyridone-5-carboxamide | 20567778 |
| C024058 | N(1)-methylnicotinamide | LEPR affects the abundance of N(1)-methylnicotinamide | 20567778 |
| C583365 | N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide | "N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of LEPR mRNA" | 29244179 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of LEPR mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of LEPR mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of LEPR mRNA" | 25620056 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the abundance of Glucose] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the activity of FASN protein] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the activity of G6PD protein] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the activity of HMGCR protein] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the expression of G6PC mRNA] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the expression of GCK mRNA] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the expression of PCK1 mRNA] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the expression of PPARG protein] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the expression of SLC2A2 protein] | 16427799 |
| C005274 | naringin | naringin affects the reaction [LEPR protein affects the expression of SLC2A4 protein] | 16427799 |
| C005274 | naringin | naringin inhibits the reaction [Glucose results in increased expression of LEPR protein] | 24399619 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of BTC mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of DDHD1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of PCK1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of TTPA mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of UCP1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ASPH mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of CASQ1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of EDNRB mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of ENO3 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of GPI1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of NRAP mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of RALGAPA1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of SRL mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TLN1 mRNA] | 16940432 |
| D009525 | Niacin | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TPM1 mRNA] | 16940432 |
| D009532 | Nickel | Nickel results in decreased expression of LEPR mRNA | 24768652 |
| C037645 | nicotinamide N-oxide | LEPR affects the abundance of nicotinamide N-oxide | 20567778 |
| D009538 | Nicotine | Nicotine results in decreased expression of LEPR mRNA | 29155039 |
| D009538 | Nicotine | Nicotine results in increased expression of LEPR mRNA | 22265867 |
| C005211 | N'-methyl-2-pyridone-5-carboxamide | LEPR affects the abundance of N'-methyl-2-pyridone-5-carboxamide | 20567778 |
| C038780 | n-pentanoic acid | LEPR affects the abundance of n-pentanoic acid | 20567778 |
| C572462 | octaphlorethol A | [octaphlorethol A co-treated with LEPR gene mutant form] results in increased expression of SLC2A4 protein | 26939912 |
| C572462 | octaphlorethol A | [octaphlorethol A co-treated with LEPR gene mutant form] results in increased phosphorylation of AKT1 protein | 26939912 |
| C572462 | octaphlorethol A | octaphlorethol A inhibits the reaction [LEPR gene mutant form results in increased expression of FASN mRNA] | 26939912 |
| C572462 | octaphlorethol A | octaphlorethol A inhibits the reaction [LEPR gene mutant form results in increased expression of G6PC mRNA] | 26939912 |
| C572462 | octaphlorethol A | octaphlorethol A inhibits the reaction [LEPR gene mutant form results in increased expression of INS1 protein] | 26939912 |
| C572462 | octaphlorethol A | octaphlorethol A inhibits the reaction [LEPR gene mutant form results in increased expression of PCK1 mRNA] | 26939912 |
| D000069463 | Olive Oil | Olive Oil analog affects the expression of LEPR mRNA | 17349074 |
| D000069463 | Olive Oil | Olive Oil results in decreased expression of LEPR mRNA | 23038630 |
| D015525 | Fatty Acids, Omega-3 | "Fatty Acids, Omega-3 results in increased expression of LEPR mRNA" | 15949695 |
| D009963 | Orotic Acid | LEPR affects the abundance of Orotic Acid | 20567778 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of LEPR mRNA | 26516004 |
| D010126 | Ozone | LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CCL11 protein] | 16373670 |
| D010126 | Ozone | LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CXCL1 protein] | 16373670 |
| D010126 | Ozone | LEPR gene mutant form promotes the reaction [Ozone results in increased expression of CXCL2 protein] | 16373670 |
| D010126 | Ozone | LEPR gene mutant form promotes the reaction [Ozone results in increased expression of IL6 protein] | 16373670 |
| D010126 | Ozone | LEPR gene mutant form results in increased susceptibility to Ozone | 16373670 |
| C016030 | pantogab | pantogab results in increased expression of LEPR mRNA | 17379144 |
| D010269 | Paraquat | Paraquat affects the expression of LEPR mRNA | 25064622 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 25510870 |
| C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with PCB 180] results in decreased expression of LEPR mRNA" | 24978599 |
| C046012 | pentanal | pentanal results in decreased expression of LEPR mRNA | 26079696 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of LEPR mRNA | 17681415 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of LEPR mRNA | 24535843 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of LEPR mRNA | 23091169 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of LEPR mRNA | 22008536 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LEPR mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of LEPR mRNA | 26272509 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LEPR mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of LEPR mRNA | 18301758|1844570 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of LEPR mRNA | 19162173 |
| D011374 | Progesterone | LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]] | 19849856 |
| D011433 | Propranolol | Propranolol results in increased expression of LEPR mRNA | 24250662 |
| D011441 | Propylthiouracil | Propylthiouracil affects the expression of LEPR mRNA | 24780913 |
| C432165 | pyrazolanthrone | LEPR protein affects the susceptibility to pyrazolanthrone | 22933112 |
| D011794 | Quercetin | Quercetin results in increased expression of LEPR mRNA | 22230496 |
| D011794 | Quercetin | Quercetin results in increased expression of LEPR protein | 22230496 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] | 22426011 |
| D011929 | Razoxane | Razoxane results in decreased expression of LEPR mRNA | 19915844 |
| C059514 | resveratrol | resveratrol inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| C059514 | resveratrol | resveratrol inhibits the reaction [LEPR gene mutant form results in increased abundance of Superoxides] | 19478208 |
| C013672 | riddelliine | riddelliine results in increased expression of LEPR mRNA | 18047727 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [LEPR protein affects the expression of INS1 protein] | 19452630 |
| D012431 | Rutin | Rutin inhibits the reaction [Fructose results in increased expression of and results in increased phosphorylation of LEPR protein] | 22426011 |
| C093642 | SB 203580 | LEPR protein affects the susceptibility to SB 203580 | 22933112 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of LEPR mRNA | 25895662 |
| D019821 | Simvastatin | LEPR polymorphism affects the susceptibility to Simvastatin | 14625131|1885499 |
| C017947 | sodium arsenite | LEPR gene mutant form inhibits the reaction [sodium arsenite results in increased abundance of Blood Glucose] | 25367288 |
| C017947 | sodium arsenite | LEPR gene mutant form inhibits the reaction [sodium arsenite results in increased secretion of INS1 protein] | 25367288 |
| C017947 | sodium arsenite | sodium arsenite inhibits the reaction [LEPR gene mutant form results in increased abundance of Blood Glucose] | 25367288 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of LEPR mRNA | 25993096 |
| D017673 | Sodium Chloride, Dietary | "LEPR gene mutant form results in increased susceptibility to Sodium Chloride, Dietary" | 22949526 |
| D017673 | Sodium Chloride, Dietary | "LEPR gene mutant form results in increased susceptibility to Sodium Chloride, Dietary deficiency" | 22949526 |
| D053260 | Soot | Soot results in decreased expression of LEPR mRNA | 26551751 |
| D019802 | Succinic Acid | LEPR affects the abundance of Succinic Acid | 20567778 |
| D013395 | Sucrose | LEPR affects the abundance of Sucrose | 20567778 |
| D013481 | Superoxides | acetovanillone inhibits the reaction [LEPR gene mutant form results in increased abundance of Superoxides] | 19478208 |
| D013481 | Superoxides | LEPR gene mutant form results in increased abundance of Superoxides | 19478208 |
| D013481 | Superoxides | resveratrol inhibits the reaction [LEPR gene mutant form results in increased abundance of Superoxides] | 19478208 |
| D013619 | Tacrine | Tacrine results in increased expression of LEPR mRNA | 12832660 |
| D013654 | Taurine | LEPR affects the abundance of Taurine | 20567778 |
| C001803 | tempol | tempol inhibits the reaction [LEPR gene mutant form results in decreased susceptibility to Acetylcholine] | 19478208 |
| D013739 | Testosterone | LEPR protein affects the abundance of Testosterone | 15093691 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LEPR mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of LEPR mRNA | 20106945 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LEPR mRNA | 26377647|2892240 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LEPR mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of LEPR mRNA | 26290441 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of LEPR mRNA | 15977195|2229881 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of LEPR mRNA | 20959002|2172422 |
| D013752 | Tetracycline | Tetracycline affects the expression of LEPR mRNA | 25064622 |
| D013853 | Thioacetamide | Thioacetamide affects the expression of LEPR mRNA | 25064622 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of LEPR mRNA | 17997003 |
| D013853 | Thioacetamide | LEPR gene mutant form inhibits the reaction [Thioacetamide results in increased expression of TGFB1 mRNA] | 11984526 |
| D013853 | Thioacetamide | LEPR protein affects the reaction [Thioacetamide results in increased expression of TGFB1 mRNA] | 11984526 |
| D013853 | Thioacetamide | Lipopolysaccharides inhibits the reaction [Thioacetamide results in decreased expression of LEPR mRNA] | 17621560 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of LEPR mRNA | 17621560|2341159 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of LEPR protein | 17621560 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of LEPR mRNA | 23557971 |
| D019772 | Topotecan | LEPR protein affects the susceptibility to Topotecan | 16217747 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of LEPR mRNA | 25549359 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of LEPR | 22560341 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of LEPR mRNA | 24935251 |
| C009560 | trigonelline | LEPR affects the abundance of trigonelline | 20567778 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of LEPR mRNA | 19042947 |
| C040533 | trimethyltin chloride | trimethyltin chloride results in increased expression of LEPR mRNA | 23000284 |
| C005445 | triphenyl phosphate | "ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA]" | 29112739 |
| C005445 | triphenyl phosphate | "[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA" | 29112739 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA]" | 29112739 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA" | 29112739 |
| D014317 | Tritolyl Phosphates | "ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA]" | 29112739 |
| D014317 | Tritolyl Phosphates | "[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA" | 29112739 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of LEPR mRNA | 25064622 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of LEPR mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of LEPR mRNA | 23179753|2493525 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of LEPR mRNA | 24489787 |
| D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of LEPR gene | 25560391 |
| D010205 | Pantothenic Acid | LEPR affects the abundance of Pantothenic Acid | 20567778 |
| D015032 | Zinc | [Zinc deficiency co-treated with Ethanol] results in increased expression of LEPR mRNA | 24155903 |
| D015032 | Zinc | [LEPR gene mutant form results in increased susceptibility to Ethanol] which results in decreased abundance of Zinc | 15475485 |
| D015054 | Zymosan | LEPR protein affects the susceptibility to Zymosan | 15142272 |